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Bone marrow-derived precursor T cells differentiate intrathymicallyinto mature
T cells under selective forces that are largely unknown. Thymic differentiation is
believed to require both "negative"and "positive" selection(1-3). The TCR is clearly
involved in the process ofnegative selection ortolerance induction(1, 4-6). Recently,
results from a variety ofexperimental systems demonstrated that tolerance induc-
tion, atleast forcertain self-antigensexpressed inthethymus, occurs through clonal
deletion ofT cellswith self-reactiveTCRs(1, 5, 6). SuchT cells with TCR specificity
for self-antigen appear to be deleted after the double-positive stage (CD4+/CD8+)
of thymocyte development (7-9).
One proposed model used to describe the process ofpositive selection argues that
only T cells with low avidity for self-MHC glycoproteins expressed in the thymus
are allowed to become functional and to be exported to the periphery; thus, posi-
tively selected (2, 3). This model is largely based on studies with radiation-induced
bone marrow chimeras and thymus-engrafted mice, which, given the complexities
ofsuch experimental systems, have generated some controversy with respect to the
model ofpositive selection (10, 11).
Additional support forthis model came fromin vivo studies inneonatal mice that
demonstrated that MHC glycoproteins play a crucial role during T cell develop-
ment. CD4+ T cells failed to develop in anti-class II-suppressed mice (12); whereas
CD8+ T cells failed to develop in anti-class I-suppressed mice (13). Thus, differen-
tiation ofprecursorTcells into mature T cellsinvolves selectiononthe basisoftheir
MHC specificity. Subsequent studies in Fl neonatal mice (Ia-k/Ia-b) established
thatthe appearanceofThcellprecursors restricted by either Ia-korIa-bis specifically
inhibitedby treatment withanti-la-kor anti-la-b antibodies, respectively (14). These
results were consistent with the notion that TCR-MHC interactions mediate the
recognition events necessary for positive selection(14). Otherexperimental support
for this notion was provided by studies in transgenic mice (9, 15, 16), and by studies
in anti-class I mAb-treated mice (17, 18), or antiTCRtreated mice (19).
While TCRMHC interactions are indeed crucial in the positive selection pro-
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cess, other interactions, such as those between MHC antigens and accessory mole-
cules (20, 21), may be essential as well. The present study analyzes the possible role
of CD4-ligand interactions in early T cell development. The role of CD4 in T cell
activation is by no means clear, but its contribution to the process ofT cell selection
is suggested by the observation that CD4 is involved in aiding class II MHC-re-
stricted recognition of antigen by mature (CD4') T cells; either through a direct
binding of class II MHC (22-26), or by providing an additional signal (27-31).
The concept that CD4 participates at least in negative selection is supported by
the recent observation that blocking of CD4 allowed self-reactive T cells to escape
clonal deletion at the CD4'/CD8' stage, thus permitting the generation of CD8'
cells with self-reactive TCRs, which otherwise would not have survived (7, 8). Fur-
ther evidence for the involvement of accessory molecules during negative selection
comes from experiments using transgenic mice, in which autoreactive T cells were
shown to be deleted at the double-positive stage (9). Our recent findings show that
engagement of the CD4 molecule on thymocytes results in the modulation of the
expression ofCD3/TCR (32), suggesting a function for CD4 as a signal-transducing
molecule in thymocytes. Both avidity enhancement and signal transduction func-
tions of the CD4 molecule may add to the selective forces that T cells encounter
during their journey through the thymus.
This paper examines the role of the interactions between CD4 and its ligand in
the generation of the T cell repertoire. To this end, the effects of blocking CD4 with
an anti-CD4 mAb during T cell development were analyzed in vivo and in vitro.
The in vivo experiments involved the treatment of pregnant mice with anti-CD4
mAb, while the fetal thymus organ culture (FTOC)' system was used to further
analyze the developmental function of the CD4 molecule during intrathymic selec-
tion in vitro by comparing the effects of monovalent and divalent anti-CD4 mAbs.
The results from these studies indicate that treatment with intact, bivalent, or monova-
lent anti-CD4 mAbs prevent the generation of CD4'/CD8- T cells; thus, strongly





Timed pregnant C57BL/6 mice were obtained from TheJackson Laboratory (Bar
Harbor, ME). The day ofobservation ofa vaginal plug was designated as day 0 ofembryonic
development. Pregnant female mice were killed by cervical dislocation and embryos dissected
from the uterus. Thymus lobes were dissected from the embryos using a dissecting micro-
scope and fine watchmaker's forceps.
Fetal Thymus Organ Culture.
￿
Intact fetal thymus lobes were removed from day 15 embryos
and placed in organ culture as previously described (33, 34). Briefly, four to six individual
fetal thymus lobes (N2-4 mm in between each lobe) were placed on the surface of 0.8-pm
Nucleopore filters (Thomas Scientific, Philadelphia, PA), that had been boiled for 30 min
in distilled waterbefore use. Filters were supported by a Gelfoam gelatin sponge (sterile, size
20 x 60 x 7 mm; Upjohn Co., Kalamazoo, MI). Each sponge was placed in a well ofa tissue
culture plate (No. 3506; Costar, Cambridge, MA) (six wells/plate) and soaked in 3 ml ofcul-
ture medium. The culture medium used was Dulbeccds modified Eagle's medium sup-
plemented with 10% FCS, 2 mM glutamine, 10 U/ml penicillin, 100 Ftg/ml streptomycin,
100,ug/ml gentamicin, 0.11 mg/ml sodium pyruvate, 5 x 10-' M 2-ME, and 10 mM Hepes.
1 Abbreviation used in this paper: FTOC, fetal thymus organ culture.ZU&IGA-PFLIJCKER ET AL .
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Cultures were incubated for 7-9 d at 37°C in a humidified incubator containing 7.5% C02
in air. At the end of the culture period, the thymic lobes were mechanically disrupted by
placing them on a fine nylon mesh and were squeezed by scraping the nylon mesh surface
with the tip of a syringe plunger. The cell suspension was passed through a second fine nylon
mesh to ensure a single cell suspension ; cells released were free of connective tissue. After
washing in cold PBS, cells were resuspended forFACS analysis . Viability of cell suspensions
was determined by the trypan blue exclusion test .
Antibodies and Treatments.
￿
The anti-CD4 mAb, GK1.5 (35), and the anti-class II mAb,
Y3P specific for la-b (36), were purified from nude mice ascites byammonium sulfate precipi-
tation and size separation. For in vitro treatments, either intact, F(ab')2 or Fab anti-CD4
mAb, or intact anti-class II mAb were added every day during the culture period, in a final
volume of 30 pl applied on top of the lobes at a concentration of 0.2-2 mg/ml, depending
on the experiment (see legends) . F(ab')2 fragments were prepared as previously described
(37), and Fab fragments were prepared according to standard papain digestion protocols (38) .
The F(ab')2 and Fab fragment preparations of anti-CD4 mAb were analyzed by SDS-PAGE
and shown to contain no detectable intact anti-CD4 . Anti-CD4 activity ofthe fragments was
demonstrated by their ability to block staining with FITC- or biotin-conjugated anti-CD4
mAb . Absence of intact anti-CD4mAb was further demonstrated by the failure of the F(AV)2
fragments to cause depletion of CD4'/CD8- T cells when injected into adult mice, in a
regimen leading to depletion when intact anti-CD4 mAb is used (data not shown ; see also
references 37 and 39) . Finally, Fab fragments were shown to be also "functionally" free of
intact anti-CD4, by their inability to cause modulation of cell surfaceCD4; intact anti-CD4,
in contrast, causes rapid modulation ofCD4 at 37°C (data not shown ; see also reference 30) .
Controls consisted of saline, once it had been demonstrated that equal doses ofirrelevant
rat mAb had no effect (data not shown) . For in vivo treatments with anti-CD4 mAb, preg-
nant mice were treated from day 15 of pregnancy with a daily dose of 1 mgGK1 .5, i.p ., and
thymocyte suspensions from babies were analyzed on the day of birth. Controls consisted
ofsaline, once it had been demonstrated that irrelevant ratmAb had no effect (data not shown) .
Sortingfor CD4'/CD8' T Cells.
￿
Thymic cell suspensions were enriched for T cells ex-
pressing CD4'/CD8' by three cycles of panning with mAbs to CD4 andCD8 absorbed onto
a plastic dish surface, as previously described (40); adherent cells (CD4'/CD8' ; >98% pu-
rity) were analyzed by flow cytometry for the coexpression of CD4 and CD8 .
Fluorescence Staining
￿
Cell suspensions were prepared in HBSS (without phenol red) con-
taining 1 1 7o BSA and 0.1% sodium azide (FACS buffer) . Cells (106/100 JAI buffer) were in-
cubated on ice for 30 min with 10 pl of the appropriate antibody, and washed twice after
each incubation . Control staining of cells, either stained with irrelevant antibody or with
second antibody alone, were used to obtain background fluorescence values . The samples
were analyzed on a FACS 440 (Becton Dickinson & Co., Mountain View, CA) interfaced
to a PDP 11/24 computer as previously described (12) . Data were collected on 50,000 cells
and are shown as contour diagrams, with a three-decade log scale of green fluorescence on
the x-axis, and a three-decade log scale of red fluorescence on they-axis . Reagents used for
direct staining were FITC- or biotin-conjugated anti-CD3 (41), -CD4 (35), -CD8 (42), and





The FTOC system allows for the in vitro differenti-
ation of immature, CD3-/CD4-/CD8-, day 15-16 murine fetal thymocytes into T
cells with amature phenotype (Fig. 1 ; control FTOC as compared with fresh thymus ;
see also reference 44). To analyze whether T cell development in FTOC is subject
to selective forces similar to those affecting T cell development in vivo, we examined
the effects ofblocking class IIMHC antigens in vitro. Neonatal class II suppression
in vivo results in the failure to generate CD4'/CD8- matureT cells (12) . FTOCs
treated with anti-class II mAb also fail to develop the CD4 single-positive mature2088
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Two-parameter flow cytometry analysis of cell surface CD4 vs . CD8 expression ou
FTOC treated with anti-class II mAb . Left, untreatedyoung adult thymus ; middle, control (un-
treated) FTOC ; right, anti-class II-treated FTOC. Day 15 fetal thymuses from C57BL/6 mice
were cultured for8d ; anti-class II-treated cultures received daily additions of30 A1 ofa solution
of 2 mg/ml purified anti-la(b) mAb (final concentration 20 Ftg/ml) ; control cultures received ir-
relevant mAb .
T cell population (Fig. 1) . These results show a perfect correlation with the results
previously obtained in in vivo anti-class II-treated mice (12) ; that is, only the
CD4+/CD8- T cells fail to mature, and the generation of the other main T cell
subsets (CD4-/CD8- , CD4-/CD8', and CD4+/CD8+) remains intact .
Anti-CD4 Treatment ofFTOC
￿
The above observations raisethequestion ofwhether
theseresultsareareflection of blockedTCR-class II interaction, blockedCD4-class
II interaction, or both . To test the possible contribution ofCD4-ligand interactions
toT cell development, the effect ofanti-CD4 treatment in vitro was analyzed . Con-
trol FTOCs give rise to bright CD5+(Ly1)/CD8 - T cells (Fig. 2), which correspond
to the presence ofCD4'/CD8- cells (45) . In contrast, organ cultures treated with
anti-CD4 mAb fail to develop the bright CD5+/CD8- T cell population (Fig . 2) .




cytometry analysis of cell sur-
face CD4 (left) or CD5 (right)
vs . CD8 expression on FTOC
treated with anti-CD4 mAb. Top
panels, control (untreated)FTOC;
bottom panels, anti-CD4-treated
FTOC . Day 15 fetal thymuses
from C57BL/6 mice were cul-
tured for 8 d; anti-CD4-treated
cultures received daily additions
of 30 Al ofa solution of1mg/ml
purified anti-CD4 mAb (final
concentration 10 Wg/ml); control
cultures received irrelevant mAb.ZUNIGA-PFLLICKER ET AL.
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the FTOC, but still reveals identical findings: no effects on the generation of
CD4-/CD8 + and CD4+/CD8+ cells are observed. Indirect staining demonstrated
the presence of the CD4+/CD8+ subset, in which CD4 is both blocked and down-
modulated due to the presence of the mAb; indirect staining also showed the ab-
sence of the CD4+/CD8- subset (data not shown). Anti-CD4-treated, as well as
control, FTOCs contain adull CD5'/CD8- population that corresponds to CD4-/
CD8- T cells (45). Additionally, CD5+/CD8+ cells, corresponding to CD4+/CD8+
T cells, and CD5-/CD8+ (CD4-/CD8+ single positive), are also present in both con-
trol and treated FTOC. It therefore appears that the anti-CD4 treatment selectively
blocks thedevelopment~Vfonly the CD4 single-positive T cells. Anti-CD8 mAb treat-
ment has no effect on the generation of CD4+/CD8 - cells (data not shown), and
its effect on other parameters of T cell development is currently being investigated.
Selective removal of CD4+/CD8- cells by the anti-CD4 mAb seems an unlikely ex-
planation for the present results, since CD4+/CD8' cells bind the mAb equally well,
yet their generation was not affected.
Anti-CD4 F(ab')2 or Fab Treatment of FT0C.
￿
We next examined the mechanisms
by which the anti-CD4 mAb might exert its effects. First, the possible contribution
of Fc-mediated processes needed to be considered. The Fc portion may be respon-
sible forthe direct activation of thecomplement system, or removalby macrophages
activated through their Fc receptors. The use of F(ab')2 fragments would exclude
these possibilities. Second, the possible contribution ofCD4crosslinking can be tested
by comparing the effects of intact vs. Fab mAb treatment. Effective treatment with
Fab fragments could not easily be achieved in vivo because the antibody fragment
was rapidly cleared before accomplishing its function (data not shown); the FTOC
system allowed us to specifically overcome this problem.
Organ-cultured fetal thymic lobes treated with F(ab')2 fragments (>95% purity
as determined by SDS-PAGE analysis) did not give rise to single-positive CD4 T
cells (Fig. 3). Theresultswere analogousto those obtained with the intact anti-CD4
mAb(Fig. 2); therefore, Fc-mediated mechanisms cannot be responsible for the ab-
sence of the CD4+ T cells. Most importantly, the F(ab')2 fragments used did not
cause depletion of CD4+/CD8 - T cells when injected into adult mice (data not
shown), in keeping with reports by others (37, 39). Thus, these results indicate that
the effects of the anti-CD4 treatment are either due to the engagement or blocking
of CD4, rather than to the direct removal of CD4+/CD8- T cells, and are compat-
ible with the observation that CD4+/CD8+ cells are not removed (see above).
Furthermore, FTOC treatment with Fab fragments of anti-CD4, containing no
detectable intact anti-CD4 (>99% purity by SDS-PAGE), generates a population
of thymocytes in which the CD4+/CD8- are likewise lacking (Fig. 3). The use of
Fabfragments precludesthepossible effects generatedby CD4crosslinking; indeed,
Fab fragmentsdid not modulate CD4, while intact anti-CD4 did (not show). These
observations also provide further functional evidence for the lack of contaminating
intact anti-CD4 mAb in the Fab fragment preparations. Taken together, these ob-
servations suggest that blocking ofCD4resultsin thefailure to generate CD4 single-
positive T cells. Also, theobserved effects are not relatedto crosslinking, but, rather,
to steric hindrance of crucial interactions requiring the CD4 molecule. Such inter-
actions might involve either an activation-induced physical association between the
CD4molecules and theCD3/TCR complex (27-29, 31), or binding of CD4 to class2090
￿




cytometry analysis of cell sur-
face CD4 (left) or CD5 (right)
vs . CD8 expression on FTOC
treated with anti-CD4 F(ab')2
or Fab mAbfragments . Toppan-
els, control FTOC ; middle pan-
els, anti-CD4-F(ab')2-treated
FTOC ; bottompanels, anti-CD4-
Fab-treatedFTOC. Day 15 fetal
thymuses from C57BL/6 mice
were cultured for8d ; anti-CD4-
treated cultures received daily
additions of 30 td of a solution
of 1 mg/ml purified anti-CD4
F(ab')2 or Fab mAb fragments
(final concentration 10 wg/ml) ;
control cultures received irrele-
vant mAb .
II MHC (22-26) . Our results suggest that anti-CD4-induced inhibition of the ap-
pearance of CD4+/CD8 - cells is related to the anti-CD4 mAb's effect on the func-
tion of the CD4 molecule during T cell development . This may result not only in
a decrease in avidity between T cells and selecting elements, but also lead to an
interference with otheryet unknown signals that affect the selection process . While
the present data does not distinguish between prevention of positive signals or in-
duction of negative signals, it is clear that such signaling would not require cross-
linking. Effectsofmonovalent anti-CD4 may reflect the prevention of an activation-
induced physical association between CD4 and theTCR complex (27-29, 31) . Re-
gardless of the mechanism for the observed perturbation in the development of
CD4+/CD8 - cells, these findings provide strong evidence for the conclusion that
interactions requiring the CD4 molecule are crucial to the generation of mature
single-positive CD4 T cells .
Anti-CD4 Treatment of Pregnant Mice.
￿
The above results strongly suggest that en-
gagement of the CD4 molecule plays a major role in the positive selection of
CD4+/CD8 - T cells in vitro . To address the veracity of these in vitro results, preg-
nant mice were subjected to anti-CD4 treatment .
Clearly, in vivo anti-CD4 treatment generated results similar to those obtained
with theFTOC system (Fig . 4, compared with Figs . 2 and3) . Pregnant mice treated
with anti-CD4 mAb gave birth to neonates that lacked CD4 single-positive or bright
CD5+/CD8 - T cells in their thymi (Fig. 4) ; the other phenotypes remained un-
changed. Again, it should be emphasized that double-positive T cells develop nor-
mally in the treated mice . Together with the observation that, as with the FTOC,
F(ab')2 fragments had identical effects as intact anti-CD4 mAbs (data not shown),
these findings exclude the possible effects of Fc-mediated events . Since F(ab')2 frag-






analysis ofcell surfaceCD4 (left) orCD5
(right) vs . CD8 expression on neonatal
thymocytes from C57BL/6pregnant mice
treated with anti-CD4 mAb. Top panels,
neonatal thymocytes from control (un-
treated) pregnant mice; bottompanels, neo-
natal thymocytes from anti-CD4-treated
pregnant mice. Day 15 pregnant mice were
treated with adaily dose of 1 mg purified
anti-CD4mAb; control mice received ir-
relevantmAb . Thymocytes were analyzed
on the day of birth .
above) ; these results indeed demonstrate that the absence ofCD4 single-positiveT
cells in fetalthymisubjectedto anti-CD4 treatment is not dueto depletion, butrather,
is caused by afailure ofpositive selection, attributable to blockedCD4-ligand inter-
actions .
Our results indicate that, in vitro and in vivo, theCD4 molecule is critically in-
volved in the selection process that leads to the development ofmature CD4 single-
positive T cells.
CD31T R Modulation in Anti-CD4-treatedFT0C andPregnant Mice.
￿
The observed
effects of anti-CD4 mAbmay reflect either its ability to decrease the avidity of the
interactionbetweendeveloping thymocytes and class 11MHC-expressing cells(22-27),
and/or reflect its ability to provide additional signals upon exposure of thymocytes
to anti-CD4 . WhetherCD4 can also function as a signaling molecule in developing
thymocytes is unknown, but our recent findings (reference 32 and below) suggest
that it may .
Occupancy of the CD4 molecule by an anti-CD4 mAb results in a substantial
increase in CD3 expression in treated fetal thymic organ cultures (Fig. 5 a) . The
CD3 upregulation occurs also in vivo ; in pregnant mice, anti-CD4 treatments lead
to an increased expression of both CD3 and the TCR-cdo (data not shown ; see ref-
erence 32) in the thymus of the fetus, indicating once more that the FTOC and
in vivo systems correlated well . Expression of several other cell surface molecules
(CD8, Thy-1, andJ11D) was not affected, in keepingwith our recent reporton anti-
CD4 effects in neonatal mice (32) . As reported before, the increase in CD3 expres-
sion occurs primarily in the double-positive (CD4+/CD8+) cells (data not shown ;
see reference 32) .
We next investigated whether this increase in CD3 is a reflection ofa "feedback"
mechanism operating to compensate for the loss of bright CD3+/CD4+/CD8 - T
cells . Failure to generate CD4+/CD8- T cells can be achieved either by anti-class
11 mAb treatment (Fig . 1, and reference 12), or by anti-CD4 mAb treatment (Figs.
2 and 3) . However, treatment with anti-class 11 mAb did not result in a significant
change in CD3 expression (Fig. 5 d), while treatment with anti-CD4 mAb does up-2092
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FIGURE 5 .
￿
Flow cytometry analysis of cell surface CD3 expression on FTOC . (a) Anti-CD4-
treatedFTOC (solid line), control FTOC (dashed line) ; (b) anti-CD4 F(ab')2-treated FTOC (solid
line), controlFTOC (dashed line) ; (c) anti-CD4 Fab-treatedFTOC (solid line), controlFTOC (dashed
line) ; (d) anti-class II-treated FTOC (solid line), control FTOC (dashed line). (a-d) Dotted line
indicates staining with irrelevantmAb . Day 15 fetal thymuses from C57BL/6 mice were cultured
for 8 d ; cultures were treated with 30 A1 of a solution of purified mAb (see Figs . 1-3).
regulateCD3 (Fig . 5a) . Thus, the upregulatedCD3 expression is not aconsequence
of the removal ofCD4+/CD8- T cells or blocking of thymocyte-class II MHC in-
teractions by anti-class II mAb. Rather, these results indicate that the upregulated
CD3 expression is a direct consequence of the binding ofanti-CD4mAb to double-
positive thymocytes .
Finally, we compared the effects ofintact F(ab')2 and Fab fragments ofanti-CD4
mAb on CD3/TCR upregulation in FTOC . Absence of intact anti-CD4 mAb in
these fragments was verified by SDS-PAGE analysis, and by the inability of these
preparations to cause depletion ofCD4+/CD8- T cells through repeated adminis-
trations of the fragments to adult mice (data not shown; see also references 37 and
39) . Surprisingly, we observed that not only the bivalent anti-CD4, F(ab')2, mAb,
but also the monovalent anti-CD4, Fab, mAb (Fig. 5, b and c) caused CD3/TCR
upregulation . This effect was seen with threedifferent preparations ofanti-CD4 Fab
fragments, all ofwhich contained no detectable intact anti-CD4 mAb, and did not
modulateCD4expression (data not shown) . Thus, theCD3/TCRupregulation does
not require crosslinking ofCD4, but appears to be solely a consequence of blocked
CD4-ligand interactions . Alternatively, monovalent (noncrosslinking) engagement
of CD4 transduces a signal resulting in CD3 upregulation . Studies are currently
in progress to determine whetherotherparameters reflecting CD4 signaling require
crosslinking .
A role for CD4 as a signaling molecule in mature T cells was already suggestedZUNIGA-PFLLJCKER ET AL.
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in previous studies (27-31); it has now been extended to neonatal (32) and prenatal
(present study) Tcells. To what extent this upregulated TCR/CD3 level contributes
to the failure to generate CD4 cells is not clear. If the TCR/CD3 complex is func-
tional, one can postulate that CD4+/CD8- T cells are not generated because pre-
cursors with high levels of TCR/CD3 are "negatively .selected." Alternatively, the
failure to generate CD4+/CD8- T cells may be solely a consequence ofthe blocked
physiological C134-class II interactions, and occurs regardless ofthe increased TCR
level. In this interpretation, the immature CD4+/CD8+ T cells have upregulated
their CD3/TCR (after CD4 engagement by the mAb), yet it would appear that this
response is insufficient and cannot override the lack of C134-class II interactions,
resulting in a failure to positively select the CD4+/CD8- subset. Ourdata also sug-
gest that positive selection is a consequence of coordinate signalling through a
TCR/CD3-CD4 complex. Ifeither component ofthe complex is blocked (i.e., with
antiTCR, -class II, or-CD4), positive selection fails tooccur. Either hypothesis would
argue that CD4 signals are crucial to Tcell development, andthat positive selection
is not solely a consequence ofTCRMHC interactions with an appropriate affinity.
Taken together, our resultsindicate that the effects ofthe anti-CD4 treatment are
twofold; a selective failure to develop CD4+ single-positive T cells, under conditions
where direct depletion of CD4+/CD8- T cells can be excluded, and a CD3 upregu-
lation in double-positive T cells. These results extend the evidence for CD4 as an
avidity-enhancing and signal-transducing molecule in mature T cells to a crucial
rolein thedifferentiation ofimmature Tcells andthe selectionoftheT cellrepertoire.
Summary
We examined the possible role of CD4 molecules during in vivo and in vitro fetal
thymic development. Our results show thatfetalthymi treated with intact anti-CD4
mAbs fail to generate CD4 single-positive T cells, while the generation ofthe other
phenotypes remains unchanged. Most importantly, the use ofF(ab')2 and Fab anti-
CD4 mAb gave identical results, i.e., failure to generate CD4+/CD8- T cells, with
no effect on the generation ofCD4+/CD8+ Tcells. Since F(ab')2 and Fab anti-CD4
fail to deplete CD4+/CD8- in adult mice, these results strongly argue that the ab-
sence ofCD4+/CD8- T cells is not due to depletion, but rather, is caused by a lack
ofpositive selection, attributable to an obstructed CD4-MHC class II interaction.
Furthermore, we also observed an increase in TCR/CD3 expression afteranti-CD4
(divalent or monovalent) mAb treatment. The TCR/CD3 upregulation occurs in
the double-positive population, and may result from CD4 signaling after mAb en-
gagement, or may be a consequence ofthe blocked CD4-class II interactions. One
proposed model argues that the CD3 upregulation occurs in an effort to compensate
for the reduction in avidityor signaling that isnormally provided by the interaction
of the CD4 accessory molecule and its ligand. As a whole, our findings advocate
that CD4 molecules play a decisive role in the differentiation of thymocytes.
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